Pharmaceuticals · VANCOUVER, A1, British Columbia, Canada
$11.32
-2.20% (-$0.25)2026-08-21
Smart-Money SignalNeutral · 48/100— Insiders are net buyers over 90 days ($1.0M, 6 buys vs 2 sales)
Revenue$4.0M
Net Income-$55.4M
EPS$-0.32
Market Cap$3.5B
Price Performance
Historical data including institutional events
Company Profile
C
Carl Hansen
CEO & Executive Director
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
